Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1967 1
1968 1
1969 4
1973 1
1979 1
1980 1
1981 2
1982 1
1985 3
1986 1
1987 4
1988 2
1989 1
1990 1
1991 1
1992 5
1993 1
1994 2
1996 3
1997 4
1998 2
1999 8
2000 11
2001 8
2002 8
2003 8
2004 15
2005 6
2006 19
2007 6
2008 3
2009 3
2010 9
2011 15
2012 8
2013 13
2014 12
2015 10
2016 15
2017 23
2018 27
2019 24
2020 35
2021 30
2022 21
2023 30
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

376 results

Results by year

Filters applied: . Clear all
Page 1
Third International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions).
Elfgen C, Leo C, Kubik-Huch RA, Muenst S, Schmidt N, Quinn C, McNally S, van Diest PJ, Mann RM, Bago-Horvath Z, Bernathova M, Regitnig P, Fuchsjäger M, Schwegler-Guggemos D, Maranta M, Zehbe S, Tausch C, Güth U, Fallenberg EM, Schrading S, Kothari A, Sonnenschein M, Kampmann G, Kulka J, Tille JC, Körner M, Decker T, Lax SF, Daniaux M, Bjelic-Radisic V, Kacerovsky-Strobl S, Condorelli R, Gnant M, Varga Z. Elfgen C, et al. Among authors: leo c. Virchows Arch. 2023 Jul;483(1):5-20. doi: 10.1007/s00428-023-03566-x. Epub 2023 Jun 17. Virchows Arch. 2023. PMID: 37330436 Free PMC article. Review.
Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial.
Bebia Z, Reyes O, Jeanfreau R, Kantele A, De Leon RG, Sánchez MG, Banooni P, Gardener GJ, Rasero JLB, Pardilla MBE, Langley JM, Di Leo CM, Botelho-Nevers E, Buttery J, Laurichesse H, Madhi SA, García AM, Stanley T, Barjat T, Griffith R, Castrejón-Alba MM, de Heusch M, Dieussaert I, Hercor M, Lese P, Qian H, Tullio AN, Henry O. Bebia Z, et al. Among authors: di leo cm. J Infect Dis. 2023 Aug 11;228(3):299-310. doi: 10.1093/infdis/jiad024. J Infect Dis. 2023. PMID: 36722147 Free PMC article. Clinical Trial.
Peptide hormone relaxin: from bench to bedside.
Jelinic M, Marshall SA, Stewart D, Unemori E, Parry LJ, Leo CH. Jelinic M, et al. Among authors: leo ch. Am J Physiol Regul Integr Comp Physiol. 2018 Jun 1;314(6):R753-R760. doi: 10.1152/ajpregu.00276.2017. Epub 2018 Feb 7. Am J Physiol Regul Integr Comp Physiol. 2018. PMID: 29412692 Free article. Review.
Serelaxin: A Novel Therapeutic for Vascular Diseases.
Leo CH, Jelinic M, Ng HH, Tare M, Parry LJ. Leo CH, et al. Trends Pharmacol Sci. 2016 Jun;37(6):498-507. doi: 10.1016/j.tips.2016.04.001. Epub 2016 Apr 27. Trends Pharmacol Sci. 2016. PMID: 27130518 Review.
Hormonal genomics.
Leo CP, Hsu SY, Hsueh AJ. Leo CP, et al. Endocr Rev. 2002 Jun;23(3):369-81. doi: 10.1210/edrv.23.3.0467. Endocr Rev. 2002. PMID: 12050125 Review.
Electrochemically reconfigurable architected materials.
Xia X, Afshar A, Yang H, Portela CM, Kochmann DM, Di Leo CV, Greer JR. Xia X, et al. Among authors: di leo cv. Nature. 2019 Sep;573(7773):205-213. doi: 10.1038/s41586-019-1538-z. Epub 2019 Sep 11. Nature. 2019. PMID: 31511685
376 results